Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$10,779,044
+$644,693 QoQ
Shares Held
68,779
+3.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#167
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HANTZ FINANCIAL SERVICES, INC. holds $94,295,990 across 14 Drug Manufacturers - General names. NVS ranks #4 (11.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
84,317 | $21,413,988 | |
| 2 | LLY |
ELI LILLY & Co
|
10,017 | $12,014,691 | |
| 3 | ABBV |
AbbVie Inc.
|
45,381 | $11,419,674 | |
| 4 | NVS |
Novartis AG
This page
|
68,779 | $10,779,044 | |
| 5 | MRK |
Merck & Co., Inc.
|
66,636 | $8,562,726 | |
| 6 | GSK |
GSK plc
|
159,568 | $8,364,554 | |
| 7 | NVO |
Novo Nordisk A S
|
117,306 | $5,623,649 | |
| 8 | AZN |
Astrazeneca PLC
|
23,610 | $4,476,928 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,779,044 | 68,779 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $10,134,351 | 66,346 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $7,785,518 | 56,470 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $5,255,275 | 40,980 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $3,223,464 | 26,638 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $1,705,866 | 15,302 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,543,725 | 15,864 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $1,867,234 | 16,234 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,701,869 | 15,986 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $2,358,954 | 24,387 | Shares | Sole | 2024-08-06 | |
| 2023-12-31 | $2,501,935 | 24,779 | Shares | Sole | 2024-08-06 | |
| 2023-09-30 | $2,656,712 | 26,082 | Shares | Sole | 2024-08-06 | |
| 2023-06-30 | $3,084,213 | 30,564 | Shares | Sole | 2024-08-06 | |
| 2023-03-31 | $2,699,832 | 29,346 | Shares | Sole | 2024-08-06 | |
| 2022-12-31 | $2,652,108 | 29,234 | Shares | Sole | 2024-08-06 | |
| 2022-09-30 | $2,367,483 | 31,147 | Shares | Sole | 2024-08-06 | |
| 2022-06-30 | $2,562,104 | 30,310 | Shares | Sole | 2024-08-06 | |
| 2022-03-31 | $2,523,953 | 28,763 | Shares | Sole | 2024-08-06 | |
| 2021-12-31 | $2,208,792 | 25,252 | Shares | Sole | 2024-08-06 | |
| 2021-09-30 | $1,664,550 | 20,354 | Shares | Sole | 2024-08-06 | |
| 2021-06-30 | $1,520,332 | 16,663 | Shares | Sole | 2024-08-06 | |
| 2021-03-31 | $1,068,585 | 12,501 | Shares | Sole | 2024-08-06 | |
| 2020-12-31 | $125,214 | 1,326 | Shares | Sole | 2024-08-06 | |
| 2020-09-30 | $298,620 | 3,434 | Shares | Sole | 2024-08-06 | |
| 2020-06-30 | $288,746 | 3,306 | Shares | Sole | 2024-08-06 | |
| 2020-03-31 | $208,268 | 2,526 | Shares | Sole | 2024-08-06 | |
| No filing history on record for this holder in this stock. | ||||||